北美單位劑量製造市場規模、佔有率和趨勢分析報告：2025-2030 年按來源、產品、最終用途、國家和細分市場進行的預測

北美單位劑量製造市場的成長與趨勢

北美單位劑量製造市場規模預計到2030年將達到562.2億美元，2025年至2030年複合年成長率為11.23%。製藥業的快速成長和單位劑量需求的不斷成長是推動市場的因素。

單劑量包裝無疑已成為近年來最受歡迎的趨勢之一。最明顯的好處是易於使用和改進的藥物管理，因為它可以逐個單位進行複合，確保使用者不會超過其複合劑量。條狀包裝的特色是乾濕兩用，可用於包裝多種物品。

量杯、茶匙、湯匙以及用於口服液和眼藥水的多劑量容器已經隨處可見。今天的患者想要便利。醫生也認知到單位劑量在製定處方時的重要性。受管制藥物的口服溶液可以配製而不必擔心濫用，因為單位劑量可以解決這個問題。它還允許藥劑師以安全的方式儲存口服液體藥物，這是另一個重要的好處。這項創新有可能將幾乎所有單劑量口服固態和多劑量口服溶液轉變為單劑量口服溶液。

然而，由於COVID-19大流行的影響，2020年單位劑量製造市場與前一年同期比較去年小幅成長11.0%。 2020年終，市場開始復甦。與 COVID-19 相關的疾病正在使用單位劑量進行治療。在醫療保健領域，正在更新和實施各種新的標準作業程序，以保護病患和醫護人員。因此，消除病毒透過空氣傳播和直接接觸傳播極為重要。當使用單位劑量藥物時，與處理和注射同一瓶藥物相關的一些風險會降低。

北美單位劑量製造市場報告亮點

• 2024年，外包產業銷售額佔比最大，達60.13%，領先市場。單位劑量，加上對藥劑師工作模式和時間表的更大控制，導致藥物信用的最小化。
• 固態單位劑量細分市場在 2024 年以 49.71% 的最大收益佔有率引領市場。 2018年，口服固態製劑藥物佔FDA核准的所有新藥的53%。
• 獨立藥局細分市場在 2024 年以 37.83% 的最大收益佔有率引領市場。
• 2024 年，醫院業務佔第二大收益佔有率。單位劑量包裝可確保準確劑量，減少用藥錯誤的可能性，並支持醫院內的用藥安全通訊協定。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章：北美單位劑量製造市場變數、趨勢與範圍

• 市場體系展望
  • 母市場展望
  • 助劑市場前景
• 市場動態
  • 市場促進因素分析
  • 市場限制因素分析
• 技術景觀
• 定價模式分析
• 市場分析工具
  • 波特五力分析
  • PESTEL分析
  • COVID-19 影響分析

第 4 章 北美單位劑量製造市場：依來源估計與趨勢分析

• 細分儀表板
• 北美單位劑量製造市場：採購變化分析
• 按來源分類，2018-2030
• 公司內部
• 外包

第5章北美單位劑量製造市場：依產品估價及趨勢分析

• 細分儀表板
• 北美單位劑量製造市場：產品變化分析
• 按產品分類，2018-2030
• 液體單位劑量
• 固態單位劑量
• 其他

第6章北美單位劑量製造市場：最終用途的估計和趨勢分析

• 細分儀表板
• 北美單位劑量製造市場：最終用途變化分析
• 按最終用途分類，2018-2030
• 獨立藥房
• 長期照護設施
• 醫院
• 其他

第7章北美單位劑量製造市場：按國家、估計和趨勢分析、按來源、按產品、按最終用途

• 國家儀表板
• 國家差異分析
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥

第8章 競爭格局

• 公司分類
  • 市場領導者
  • 參與企業
• 2024 年企業市場分析（企業熱圖分析）
• 公司簡介
  • Catalent Inc.
  • Unither Pharmaceuticals
  • Thermo Fisher Scientific
  • Corden Pharma
  • Mikart
  • Tape Mark
  • Renaissance Lakewood LLC
  • Medical Packaging Inc
  • American Health Packaging
  • PCI Pharma Services
  • Amcor PLC
  • Bristol-Myers Squibb
  • AbbVie Inc.
  • Merck &Co. Inc.
  • Pfizer Inc.

North America Unit Dose Manufacturing Market Growth & Trends:

The North America unit dose manufacturing market size is expected to reach USD 56.22 billion in 2030 and is projected to grow at a CAGR of 11.23% from 2025 to 2030. The rapidly growing pharmaceutical industry and rising demand for unit doses are factors driving the market.

Single-dose packaging has certainly become one of the most popular recent trends. The most obvious benefit is its ease of use and improved medication management, as they can be prescribed by the unit, ensuring that the person taking it does not exceed the prescribed dose. Stick packs are unique in the way that they can be used to package a variety of items, both dry and wet.

Measuring cups, teaspoons, tablespoons, and multi-dose containers for oral liquids and eye drops have been already seen. The current patient is seeking convenience. Doctors are also appreciating the importance of unit dose in prescription writing since it allows them to prescribe controlled substance oral liquid without concern of abuse as unit doses address the issue. It also enables pharmacists to store oral liquids in a secure manner, which is a significant additional benefit. Nearly every single unit dose oral solid or multiple-dose oral liquid could be transformed to a unit dose oral liquid due to this innovation.

However, owing to the COVID-19 pandemic's repercussions, the unit dose manufacturing market increased at a modest 11.0% year over year in 2020. By the end of 2020, the market started to recover. COVID-19-related illnesses are being treated using unit dosages. Hospitals have updated and implemented various new standard operating procedures to protect both patients and healthcare workers. As a consequence, it's crucial to consider out viral transmission by airborne transmission or direct contact. When unit dose medicines are used, some of the risks involved with handling and pouring doses from the same bottle are reduced.

North America Unit Dose Manufacturing Market Report Highlights:

• The outsourcing segment led the market with the largest revenue share of 60.13% in 2024. Unit doses lead to the minimization of credits for drugs coupled with greater control by a pharmacist over work patterns and schedules.
• The solid unit dose segment led the market with the largest revenue share of 49.71% in 2024. In 2018, oral solid dosage medicines accounted for 53% of all new pharmaceuticals approved by the FDA.
• The independent pharmacies segment led the market with the largest revenue share of 37.83% in 2024.
• The hospitals segment accounted for the second-largest revenue share in 2024. Unit dose packaging ensures precise dosing, reduces the possibility of medication errors, and supports medication safety protocols within hospital settings.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. North America Unit Dose Manufacturing Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increased Adoption of Unit Doses
    • 3.2.1.2. Benefits of Manufacturing Unit Doses Over Repackaging
    • 3.2.1.3. Growing Outsourcing Activities
    • 3.2.1.4. Technological Advancements in Unit Dose Manufacturing
    • 3.2.1.5. Increasing Prevalence of Chronic Diseases and Demand for Personalized Medicine
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Challenges Associated with the Adoption of Manufactured Unit Doses
    • 3.2.2.2. Compliance Issues with Outsourcing
• 3.3. Technology Landscape
• 3.4. Pricing Model Analysis
• 3.5. Market Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. PESTEL analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. North America Unit Dose Manufacturing Market: Sourcing Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. North America Unit Dose Manufacturing Market: Sourcing Movement Analysis
• 4.3. North America Unit Dose Manufacturing Market Estimates & Forecasts, by Sourcing, 2018 - 2030 (USD Million)
• 4.4. In-House
  • 4.4.1. In-House Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 4.5. Outsourcing
  • 4.5.1. Outsourcing Market Estimates & Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America Unit Dose Manufacturing Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. North America Unit Dose Manufacturing Market: Product Movement Analysis
• 5.3. North America Unit Dose Manufacturing Market Estimates & Forecasts, by Product, 2018 - 2030 (USD Million)
• 5.4. Liquid Unit Dose
  • 5.4.1. Liquid Unit Dose Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 5.5. Solid Unit Dose
  • 5.5.1. Solid Unit Dose Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America Unit Dose Manufacturing Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. North America Unit Dose Manufacturing Market: End Use Movement Analysis
• 6.3. North America Unit Dose Manufacturing Market Estimates & Forecasts, by End Use, 2018 - 2030 (USD Million)
• 6.4. Independent Pharmacies
  • 6.4.1. Independent Pharmacies Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 6.5. Long Term Care Facility
  • 6.5.1. Long Term Care Facility Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 6.6. Hospitals
  • 6.6.1. Hospitals Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)

Chapter 7. North America Unit Dose Manufacturing Market: Country Estimates & Trend Analysis, by Sourcing, by Product, By End Use

• 7.1. Country Dashboard
• 7.2. Country Movement Analysis
• 7.3. North America
  • 7.3.1. North America Unit Dose Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. U.S. Unit Dose Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Canada Unit Dose Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Mexico Unit Dose Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
  • 8.1.1. Market Leaders
  • 8.1.2. Emerging Players
• 8.2. Company Market Position Analysis, 2024 (Company Heat Map Analysis)
• 8.3. Company Profiles
  • 8.3.1. Catalent Inc.
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Unither Pharmaceuticals
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Thermo Fisher Scientific
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Corden Pharma
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Mikart
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Tape Mark
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Renaissance Lakewood LLC
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Medical Packaging Inc
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. American Health Packaging
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Service Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. PCI Pharma Services
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Service Benchmarking
    • 8.3.10.4. Strategic Initiatives
  • 8.3.11. Amcor PLC
    • 8.3.11.1. Company Overview
    • 8.3.11.2. Financial Performance
    • 8.3.11.3. Service Benchmarking
    • 8.3.11.4. Strategic Initiatives
  • 8.3.12. Bristol-Myers Squibb
    • 8.3.12.1. Company Overview
    • 8.3.12.2. Financial Performance
    • 8.3.12.3. Service Benchmarking
    • 8.3.12.4. Strategic Initiatives
  • 8.3.13. AbbVie Inc.
    • 8.3.13.1. Company Overview
    • 8.3.13.2. Financial Performance
    • 8.3.13.3. Service Benchmarking
    • 8.3.13.4. Strategic Initiatives
  • 8.3.14. Merck & Co. Inc.
    • 8.3.14.1. Company Overview
    • 8.3.14.2. Financial Performance
    • 8.3.14.3. Service Benchmarking
    • 8.3.14.4. Strategic Initiatives
  • 8.3.15. Pfizer Inc.
    • 8.3.15.1. Company Overview
    • 8.3.15.2. Financial Performance
    • 8.3.15.3. Service Benchmarking
    • 8.3.15.4. Strategic Initiatives

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 North America Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
• Table 4 North America Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
• Table 5 North America Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
• Table 6 North America Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
• Table 7 U.S. Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
• Table 8 U.S. Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
• Table 9 U.S. Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
• Table 10 Canada Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
• Table 11 Canada Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
• Table 12 Canada Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Unit Dose Manufacturing Market, Market Segmentation
• Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 9 Porter's Five Forces Analysis
• Fig. 10 PESTEL Analysis by SWOT Analysis
• Fig. 11 Regional Marketplace: Key Takeaways
• Fig. 12 North America Unit Dose Manufacturing Market, for In-house, 2018 - 2030 (USD Million)
• Fig. 13 North America Unit Dose Manufacturing Market, for Outsourcing, 2018 - 2030 (USD Million)
• Fig. 14 North America Unit Dose Manufacturing Market, for Liquid Unit Dose, 2018 - 2030 (USD Million)
• Fig. 15 North America Unit Dose Manufacturing Market, for Solid Unit Dose, 2018 - 2030 (USD Million)
• Fig. 16 North America Unit Dose Manufacturing Market, for Others, 2018 - 2030 (USD Million)
• Fig. 17 North America Unit Dose Manufacturing Market, for Independent Pharmacies, 2018 - 2030 (USD Million)
• Fig. 18 North America Unit Dose Manufacturing Market, for Long Term Care Facility, 2018 - 2030 (USD Million)
• Fig. 19 North America Unit Dose Manufacturing Market, for Hospitals, 2018 - 2030 (USD Million)
• Fig. 20 North America Unit Dose Manufacturing Market, for Others, 2018 - 2030 (USD Million)
• Fig. 21 Country Outlook, 2024 & 2030
• Fig. 22 U.S. Unit Dose Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Canada Unit Dose Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Mexico Unit Dose Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)